drugset / Trial / NCT00293696
Casodex/Zoladex Biomarkers in Localised Prostate Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate anti-androgen (bicalutamide) induced biological and molecular changes in prostate comparison to chemical castration induced (goserelin) ones
Timeline
- Start
- 2004-10
- Primary completion
- —
- Completion
- 2006-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bicalutamide | Other / unclassified | 150 mg | — |
| Subject | Goserelin | Other / unclassified | 3.6 mg | — |